Boltz Raises $110M Series A; Open Drug-Design Models Pass 5M Downloads

GabriCorso · x · 2026-11-19

Boltz, a spinout from Regina Barzilay's MIT lab, announced a $110M Series A led by Bessemer Venture Partners, less than a year after leaving stealth with a $28M seed.

Boltz-1 was the first fully open-source model to reach AlphaFold 3-level accuracy; Boltz-2 added binding affinity prediction and BoltzGen designs protein binders. The open models have passed 5 million downloads, and molecular token usage has grown 50-fold since June. Six of the world's top 20 pharma companies use Boltz Lab.

The models stay free, with revenue from proprietary models, Boltz Lab and the API. The company moved from the US back to the UK and now has 40 AI researchers in its Kings Cross office in London.

Original post →

More from Venture

Venture channel →